The drug, from Takeda Pharmaceutical of Japan, will be sold under the brand name Entyvio. [Category: Biotechnology, Takeda Pharmaceutical, Crohn's Disease, Drugs (Pharmaceuticals), Colitis, Food and Drug Administration] http://rss.nytimes.com/c/34625/f/640346/s/3aaf6ca9/sc/14/l/0L0Snytimes0N0C20A140C0A50C220Cbusiness0Cfda0Eclears0Enew0Edrug0Eto0Etreat0Ecolitis0Eand0Ecrohns0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm
Read More
No comments:
Post a Comment